At the Pericarditis Alliance, we are dedicated to the proper diagnosis and treatment of pericarditis. It is estimated that 5% of all patients visiting the emergency room with nonischemic chest pain in a given year are suffering from pericarditis.
Our goal is to educate patients and medical professionals about the diagnosis and most current treatments and protocols for pericarditis, and to better recognize complicated pericarditis cases that manifest with atypical symptoms or do not respond to NSAIDs.
This Resource Page contains helpful links for patients, physicians, and providers.
US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis
July 21, 2021
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment
Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
March 18, 2021
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
January 7, 2021
Imaging-Guided Therapies for Pericardial Diseases
June 1, 2020
Rilonacept Prevents Recurrent Pericarditis: RHAPSODY
November 17, 2020
Management of Acute and Recurrent Pericarditis
January 14, 2020
The Use of Colchicine in Pericardial Diseases
December 5, 2019
Exercise Is Good for the Heart But Not for the Inflamed Pericardium?
Interleukin-1 blockade for the treatment of pericarditis
June 19, 2017
Physical Activity and acute pericarditis
February 9, 2017
Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment
November 29, 2016
2015 ESC Guidelines for Diagnosis of Pericardial Diseases
November 7, 2015
Risk of Constrictive Pericarditis After Acute Pericarditis
August 15, 2011
Prevalence of C-Reactive Protein Elevation and Time Course of Normalization in Acute Pericarditis
February 28, 2011